Research Paper Volume 16, Issue 11 pp 10033—10062
A new perspective: deciphering the aberrance and clinical implication of disulfidptosis signatures in clear cell renal cell carcinoma
Figure 5. Variations in TME in the two disulfidptosis phenotypes. (A) The result of estimation between the two disulfidoptosis phenotypes from TCGA-KIRC datasets. ns, p > 0.05; ***p < 0.001, ****p < 0.0001. (B) The heatmap showing the frequency of TME-infiltrating cells and cancer immune cycle among the two disulfidoptosis phenotypes based on ssGSEA. (C) The Wilcox test was used to evaluate the TME-related scores of different disulfidoptosis patterns. ns, p > 0.05; ***p < 0.001, ****p < 0.0001.